Ultragenyx Pharmaceutical | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Kyowa Hakko Kirin JPY 244.68B 51.65B 2024-12
MacroGenics USD 179.62M 95.69M 2024-09
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Ultragenyx Pharmaceutical Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.